Prostaglandin F2alpha: French guidelines for uterine atony management.
Tramoni
G
G
Clement
H J
HJ
Rudigoz
R C
RC
Viale
J P
JP
D000328:Adult; D000075202:Contraindications; D015237:Dinoprost / Q000008:administration & dosage / Q000627:therapeutic use*; D015232:Dinoprostone / Q000031:analogs & derivatives / Q000627:therapeutic use; D005260:Female; D005602:France / Q000453:epidemiology; D017408:Guidelines as Topic; D006801:Humans; D010120:Oxytocics / Q000008:administration & dosage / Q000627:therapeutic use*; D006473:Postpartum Hemorrhage / Q000188:drug therapy* / Q000401:mortality; D011247:Pregnancy; D014599:Uterus / Q000503:physiopathology
D010120:Oxytocics; C016767:sulprostone; D015237:Dinoprost; D015232:Dinoprostone